Atrium Therapeutics, Inc. (RNA)
7.84
-0.30
(-3.69%)
USD |
NASDAQ |
Oct 02, 16:00
7.98
+0.14
(+1.79%)
Pre-Market: 20:00
Atrium Therapeutics Price to Book Value : 0.625 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 0.625 |
| October 01, 2026 | 0.6489 |
| September 30, 2026 | 0.6601 |
| September 29, 2026 | 0.6712 |
| September 28, 2026 | 0.6712 |
| September 25, 2026 | 0.6609 |
| September 24, 2026 | 0.6529 |
| September 23, 2026 | 0.6641 |
| September 22, 2026 | 0.735 |
| September 21, 2026 | 0.7326 |
| September 18, 2026 | 0.7135 |
| September 17, 2026 | 0.7621 |
| September 16, 2026 | 0.7573 |
| September 15, 2026 | 0.8044 |
| September 14, 2026 | 0.8139 |
| September 11, 2026 | 0.8259 |
| September 10, 2026 | 0.8251 |
| September 09, 2026 | 0.8379 |
| September 08, 2026 | 0.9048 |
| September 04, 2026 | 1.131 |
| September 03, 2026 | 1.164 |
| September 02, 2026 | 1.121 |
| September 01, 2026 | 1.098 |
| August 31, 2026 | 1.062 |
| August 28, 2026 | 1.087 |
| Date | Value |
|---|---|
| August 27, 2026 | 1.114 |
| August 26, 2026 | 1.104 |
| August 25, 2026 | 1.116 |
| August 24, 2026 | 1.086 |
| August 21, 2026 | 1.052 |
| August 20, 2026 | 1.075 |
| August 19, 2026 | 1.093 |
| August 18, 2026 | 1.024 |
| August 17, 2026 | 1.033 |
| August 14, 2026 | 1.024 |
| August 13, 2026 | 0.9829 |
| August 12, 2026 | 0.9702 |
| August 11, 2026 | 0.9782 |
| August 10, 2026 | 0.9758 |
| August 07, 2026 | 0.9837 |
| August 06, 2026 | 0.9654 |
| August 05, 2026 | 0.9359 |
| August 04, 2026 | 0.92 |
| August 03, 2026 | 0.9032 |
| July 31, 2026 | 0.9048 |
| July 30, 2026 | 0.9136 |
| July 29, 2026 | 0.8913 |
| July 28, 2026 | 0.916 |
| July 27, 2026 | 0.9224 |
| July 24, 2026 | 0.916 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Tenax Therapeutics, Inc. | 0.5569 |
| Exicure, Inc. | 7.502 |
| Century Therapeutics, Inc. | 1.189 |
| Absci Corp. | 7.716 |
| Celularity, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 4.905 |
| PEG Ratio | -0.0054 |
| Price | 7.84 |
| Earnings Yield | -58.77% |
| Market Cap | 134.11M |
| PEGY Ratio | -0.0054 |